We found that O-GlcNAc and OGA increases with long-term TMG treatment in both SH-SY5Y neuroblastoma cells (Figure 2A) and HeLa cervical cancer cells (Figure 2D) while OGT decreases as expected. The gene discussed is OGT; the disease is neuroblastoma.